-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Mogroside III-A2
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/88901-43-3.gif)
| Category | Herpes simplex Virus (HSV) |
| CAS | 88901-43-3 |
| Description | Mogroside III-A2 is found in Siraitia grosvenorii. |
Product Information
| Synonyms | mogroside III A2|CHEMBL426753|HY-N8041|CS-0139022 |
| Molecular Weight | 963.15 |
| Molecular Formula | C48H82O19 |
| Canonical SMILES | CC(CCC(C(C)(C)O)OC1C(C(C(C(O1)CO)O)O)O)C2CCC3(C2(CC(C4(C3CC=C5C4CCC(C5(C)C)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O)C)O)C)C |
| InChI | InChI=1S/C48H82O19/c1-21(9-13-31(45(4,5)61)67-42-39(59)36(56)33(53)26(19-50)64-42)22-15-16-46(6)28-12-10-23-24(48(28,8)29(51)17-47(22,46)7)11-14-30(44(23,2)3)66-43-40(60)37(57)34(54)27(65-43)20-62-41-38(58)35(55)32(52)25(18-49)63-41/h10,21-22,24-43,49-61H,9,11-20H2,1-8H3/t21-,22-,24-,25-,26-,27-,28-,29-,30+,31-,32-,33-,34-,35+,36+,37+,38-,39-,40-,41-,42+,43+,46+,47-,48+/m1/s1 |
| InChIKey | PASFPXYDHLIVRF-AFBORMSVSA-N |
| Boiling Point | 1048.3±65.0 °C at 760 mmHg |
| Flash Point | 587.8±34.3 °C |
| Purity | > 95% |
| Density | 1.4±0.1 g/cm3 |
| Solubility | Soluble in Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc. |
| Appearance | Powder |
| Storage | Store at -20°C |
| Complexity | 1720 |
| Exact Mass | 962.54503038 |
| Index Of Refraction | 1.619 |
| In Vitro | Mogroside III A2 inhibits the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), with IC50 of 352 mol ratio/32 pmol TPA. Mogroside III A2 shows weak inhibitory effects on activation of (±)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1). |
| Target | Epstein-Barr virus |
| Vapor Pressure | 0.0±0.6 mmHg at 25°C |
| XLogP3-AA | 0.1 |
